Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-02
1996-07-30
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514388, 514419, 514466, 546157, 548259, 5483051, 5483064, 548491, 549445, A61K 3141, C07D24918
Patent
active
055412041
ABSTRACT:
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof wherein: R.sup.1 to R.sup.9 are as defined herein and m is the integer 0 or 1. These compounds are beta 3 adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity, gastrointestinal diseases and achalasia.
REFERENCES:
patent: 3562297 (1971-02-01), Howe et al.
patent: 3634511 (1972-01-01), Howe et al.
patent: 3655661 (1972-04-01), Wasson
patent: 3712927 (1973-01-01), Howe et al.
patent: 3812125 (1974-05-01), Wasson
patent: 3906110 (1975-09-01), Francis
patent: 3959486 (1976-05-01), LeCount et al.
patent: 4110472 (1978-08-01), Hiltmann et al.
patent: 4134983 (1979-01-01), Baldwin
patent: 4210753 (1980-07-01), Tominaga et al.
patent: 4289883 (1981-09-01), Tominaga et al.
patent: 4302588 (1981-11-01), Tominaga et al.
patent: 4338330 (1982-07-01), Gillet et al.
patent: 4338333 (1982-07-01), Ainsworth et al.
patent: 4374840 (1983-02-01), Shiratsuchi et al.
patent: 4479949 (1984-10-01), Iwao et al.
patent: 4482562 (1984-11-01), Shiratsuchi et al.
patent: 4552969 (1985-11-01), Iwao et al.
patent: 4558125 (1985-12-01), Iwao et al.
patent: 4707497 (1987-11-01), Cecchi et al.
patent: 4772631 (1988-09-01), Holloway et al.
patent: 4853383 (1989-08-01), Baldwin et al.
patent: 4990668 (1991-02-01), Mai et al.
patent: 5053514 (1991-10-01), Fujioka et al.
patent: 5061727 (1991-10-01), Bloom et al.
patent: 5198448 (1991-03-01), Fujioka et al.
patent: 5254595 (1993-10-01), Guzzi et al.
Petrov et al., Chemical Abstracts, vol. 82 (1974) 17546.
Poss Kathleen M.
Sher Philip M.
Washburn William N.
Bristol--Myers Squibb Company
Park Ellen K.
Raymond Richard L.
LandOfFree
Aryloxypropanolamine .beta. 3 adrenergic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryloxypropanolamine .beta. 3 adrenergic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryloxypropanolamine .beta. 3 adrenergic agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658961